6-K - UNILEVER PLC (0000217410) (Filer)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________________________

FORM 6-K

_________________________________________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

November 2026

Commission File

Number: 001-04546

______________________________________________________

 UNILEVER PLC

(Translation of registrant’s name into English)

 _____________________________________________________

UNILEVER HOUSE, BLACKFRIARS, LONDON, ENGLAND

(Address of principal executive office)

_____________________________________________________

Indicate by check mark whether the registrant files or will file annual reports

under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

2 November 2026

Unilever PLC

Voting Rights and Capital Update

The following notification is made in accordance with the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rule 5.6.1.

Unilever PLC’s issued share capital as at 30 October 2026 consisted of 2,185,205,247 ordinary shares of 3 1/2p each. Of those ordinary shares, 30,703,780 were held as treasury shares and 172,182 ordinary shares (including ordinary shares represented by Unilever PLC ADSs) were held by or on behalf of companies in the Unilever group (the “Unilever Group Shares”). The voting rights attaching to the Unilever Group Shares are not exercisable. Accordingly, as at 30 October 2026, there were 2,154,329,285 shares with voting rights.

The figure of 2,154,329,285 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Unilever PLC under the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

Prakash Kakkad

Chief Legal Officer and Group Company Secretary

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date 02 November 2026